|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2025―May―11 |
SARS-CoV-2 Infection Reactivates HIV-1 Replication From Latency in U1 Cells |
Xue Wang, Weichun Tang, Jiangqin Zhao, Zhiping Ye2, Hang Xie, Indira Hewlett |
2 |
[GO] |
2024―Aug―27 |
Phenotypic switch of vascular smooth muscle cells in COVID-19: Role of cholesterol, calcium, and phosphate |
Laura Ghanem, Dina Essayli, Jana Kotaich, Mohammad Al Zein, Amirhossein Sahebkar, Ali H. Eid |
3 |
[GO] |
2024―Jul―23 |
EXPRESSION OF CONCERN: Th17 and treg cells function in SARS-CoV2 patients compared with healthy controls |
|
4 |
[GO] |
2024―Jul―17 |
RETRACTION: Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients |
|
5 |
[GO] |
2023―Feb―22 |
An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19 |
Somayeh Mohammadpour, Amir Torshizi Esfahani, Mehrdad Halaji, Mina Lak, Reza Ranjbar |
6 |
[GO] |
2022―Jun―27 |
Alterations in CD39/CD73 axis of T cells associated with COVID-19 severity |
Gilson P. Dorneles, Paula C. Teixeira, Igor M. da Silva, Lucas L. Schipper, Paulo C. Santana Filho, Luiz C. Rodrigues Junior, et al. (+9) Cristina Bonorino, Alessandra Peres, Simone G. Fonseca, Marta C. Monteiro, Carina R. Boeck, Sarah Eller, Tiago F. Oliveira, Eliana M. Wendland, Pedro R. T. Romão |
7 |
[GO] |
2022―Apr―23 |
SARS-CoV-2 infection of human-induced pluripotent stem cells-derived lung lineage cells evokes inflammatory and chemosensory responses by targeting mitochondrial pathways |
Harshini Surendran, Saurabh Kumar, Swathi Narasimhaiah, Anuradha Ananthamurthy, PS Varghese, George A. D'Souza, et al. (+2) Guruprasad Medigeshi, Rajarshi Pal |
8 |
[GO] |
2021―Aug―05 |
Severe acute respiratory syndrome coronavirus-2 and its structural proteins |
Milad Zandi, Saber Soltani |
9 |
[GO] |
2021―Mar―23 |
Higher infectivity of the SARS-CoV-2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data |
Abbas Khan, Tauqir Zia, Muhammad Suleman, Taimoor Khan, Syed Shujait Ali, Aamir Ali Abbasi, et al. (+2) Anwar Mohammad, Dong-Qing Wei |
10 |
[GO] |
2021―Feb―24 |
Akt-independent effects of triciribine on ACE2 expression in human lung epithelial cells: Potential benefits in restricting SARS-CoV2 infection |
Mir S. Adil, Arti Verma, Madhuri Rudraraju, S. Priya Narayanan, Payaningal R. Somanath |
11 |
[GO] |
2020―Dec―29 |
Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients |
Safa Tahmasebi, Mohamed A. El-Esawi, Zaid Hameed Mahmoud, Anton Timoshin, Hamed Valizadeh, Leila Roshangar, et al. (+6) Mojtaba Varshoch, Aydin Vaez, Saeed Aslani, Jamshid G. Navashenaq, Leili Aghebati-Maleki, Majid Ahmadi |
12 |
[GO] |
2020―Dec―11 |
Thermal inactivation of COVID-19 specimens improves RNA quality and quantity |
Maral Hemati, Mohsen Soosanabadi, Tahereh Ghorashi, Hadi Ghaffari, Azadeh Vahedi, Elaheh Sabbaghian, et al. (+4) Zahra Rasouli Nejad, Amir Salati, Navid Danaei, Parviz Kokhaei |
13 |
[GO] |
2020―Oct―20 |
Mechanisms of COVID-19-induced cardiovascular disease: Is sepsis or exosome the missing link? |
Mallikarjun Patil, Sarojini Singh, John Henderson, Prasanna Krishnamurthy |
14 |
[GO] |
2020―Oct―06 |
Immunobiology and immunotherapy of COVID-19: A clinically updated overview |
Abdolreza Esmaeilzadeh, Reza Elahi |
15 |
[GO] |
2020―Sep―22 |
Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment |
Na Li, Lingfeng Zhao, Xianquan Zhan |
16 |
[GO] |
2020―Sep―18 |
Single-cell RNA sequencing analysis of SARS-CoV-2 entry receptors in human organoids |
Rajasekaran Mahalingam, Prakash Dharmalingam, Abirami Santhanam, Sivareddy Kotla, Gangarao Davuluri, Harry Karmouty-Quintana, et al. (+2) Guha Ashrith, Rajarajan A. Thandavarayan |
17 |
[GO] |
2020―Sep―15 |
Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls |
Armin Sadeghi, Safa Tahmasebi, Arshad Mahmood, Maria Kuznetsova, Hamed Valizadeh, Ali Taghizadieh, et al. (+7) Masoud Nazemiyeh, Leili Aghebati-Maleki, Farhad Jadidi-Niaragh, Sanaz Abbaspour-Aghdam, Leila Roshangar, Haleh Mikaeili, Majid Ahmadi |
18 |
[GO] |
2020―Sep―14 |
ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19 |
Seyed Ali Ziai, Mitrasadat Rezaei, Sajad Fakhri, Ramin Pouriran |
19 |
[GO] |
2020―Sep―10 |
Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies |
Simin Seyedpour, Behzad Khodaei, Amir H. Loghman, Nasrin Seyedpour, Misagh F. Kisomi, Maryam Balibegloo, et al. (+4) Sasan S. Nezamabadi, Bahareh Gholami, Amene Saghazadeh, Nima Rezaei |
20 |
[GO] |
2020―Jul―22 |
COVID-19 and olfactory dysfunction: A possible associative approach towards neurodegenerative diseases |
Iyer Mahalaxmi, Jayaramayya Kaavya, Subramaniam Mohana Devi, Vellingiri Balachandar |
21 |
[GO] |
2020―Jun―19 |
Vaccine development and therapeutic design for 2019-nCoV/SARS-CoV-2: Challenges and chances |
Mahnaz Ghaebi, Abdolreza Osali, Hamed Valizadeh, Leila Roshangar, Majid Ahmadi |
22 |
[GO] |
2020―Jun―08 |
Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury |
Jieyu Guo, Xiangxiang Wei, Qinhan Li, Liliang Li, Zhaohua Yang, Yu Shi, et al. (+5) Yue Qin, Xinyue Zhang, Xinhong Wang, Xiuling Zhi, Dan Meng |
23 |
[GO] |
2020―May―26 |
COVID-19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019-nCoV disease |
Roghayeh Sheervalilou, Milad Shirvaliloo, Nahid Dadashzadeh, Sakine Shirvalilou, Omolbanin Shahraki, Younes Pilehvar-Soltanahmadi, et al. (+3) Habib Ghaznavi, Samideh Khoei, Ziba Nazarlou |
24 |
[GO] |
2020―May―26 |
The outlook for diagnostic purposes of the 2019-novel coronavirus disease |
Safa Tahmasebi, Elnaz Khosh, Abdolreza Esmaeilzadeh |
25 |
[GO] |
2020―May―12 |
A global treatments for coronaviruses including COVID-19 |
Bahman Yousefi, Saeid Valizadeh, Hadi Ghaffari, Azadeh Vahedi, Mohsen Karbalaei, Majid Eslami |
|